The table below shows Arcus Biosciences, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$482.00M
-$170.00M
-$306.00M
$438.00M
-$256.00M
$111.00M
Capital expenditure
$2.00M
$6.00M
$24.00M
$6.00M
$26.00M
$3.00M
Investing cash flow
$66.00M
-$84.00M
$194.00M
-$413.00M
-$4.00M
-$434.00M
Dividends paid
-
-
-
-
-
RCUS operating cash flow (10-K history)
Arcus Biosciences, Inc. reported operating cash flow of -$482.00M for fiscal year 2025. That is down 183.5% from -$170.00M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$12.94M (FY 2016) to -$482.00M. Figures come from the company's audited annual reports as filed with the SEC.
